Biography
Amy McLeman is a Microbiologist at Liverpool School of Tropical Medicine (LSTM) focused on antimicrobial chemotherapy and resistance, drug discovery and One Health. Prior to her move to LSTM, she completed her PhD at the University of Exeter on the discovery and screening of novel pesticide compounds. Amy’s higher education background is in Zoology and Conservation (BSc) from Bangor University followed by an MSc from the University of Exeter in Conservation and Biodiversity, this gave her a strong foundation of One Health, microbiology, genetics and research as a whole. During her masters, Amy worked on bacteriophage and how they could be used for treating tomato plant infections, this then led onto her research with the University of Exeter Medical School where she continued working on phage and their co-evolution with bacteria and moved into discovery of novel antimicrobials from seaweeds.
Research interests
Amy’s research interests lie in natural product research with the aim of applying findings to tackle the problem of antimicrobial chemotherapy and resistance.
She currently works in Adam Roberts research group on the Infection Innovation Consortium project and Swab and Send. Her team aims to identify novel antimicrobial products from environmental samples and are creating an environmental isolate library. Amy is particularly focused on identifying active compounds from environmental isolates.
Selected research publications
Fly-Tox: A panel of transgenic flies expressing pest and pollinator cytochrome P450s – Journal: Pesticide Biochemistry and Physiology – Published: 20th August 2020
View more publications